Involvement of microsomal fatty aldehyde dehydrogenase in the α- oxidation of phytanic acid

N. M. Verhoeven, C. Jakobs, G. Carney, M. P. Somers, R. J.A. Wanders, William B Rizzo

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

We investigated the role of microsomal fatty aldehyde dehydrogenase (FALDH) in the conversion of pristanal into pristanic acid. Cultured skin fibroblasts from controls and patients with Sjogren-Larsson syndrome (SLS) who are genetically deficient in FALDH activity were incubated with [2,3- 3H]phytanic acid. The release of aqueous-soluble radioactivity by the SLS cells was decreased to 25% of normal, consistent with an intact formation of pristanal but a deficiency of further oxidation. SLS cells also accumulated four-fold more radioactivity in N-alkyl-phosphatidyl ethanolamine, which arises from incorporation of free aldehyde into phosphatidyl ethanolamine. Recombinant human FALDH expressed in Chinese hamster ovary cells readily oxidized pristanal and cultured fibroblasts from SLS patients showed a severe deficiency in FALDH activity (13% of normal) when pristanal was used as substrate. Nevertheless, SLS patients did not accumulate phytanic acid in their plasma. We conclude that FALDH is involved in the oxidation of pristanal to pristanic acid and that this reaction is deficient in patients with SLS.

Original languageEnglish (US)
Pages (from-to)225-228
Number of pages4
JournalFEBS Letters
Volume429
Issue number3
DOIs
StatePublished - Jun 16 1998

Fingerprint

long-chain-aldehyde dehydrogenase
Sjogren-Larsson Syndrome
Phytanic Acid
Oxidation
Ethanolamine
Radioactivity
Fibroblasts
Aldehydes
Skin
Cells
Cricetulus
pristanal
Plasmas
Ovary

Keywords

  • Aldehyde dehydrogenase
  • Peroxisomal disorder
  • Phytanic acid
  • Sjogren-Larsson syndrome

ASJC Scopus subject areas

  • Biophysics
  • Structural Biology
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Involvement of microsomal fatty aldehyde dehydrogenase in the α- oxidation of phytanic acid. / Verhoeven, N. M.; Jakobs, C.; Carney, G.; Somers, M. P.; Wanders, R. J.A.; Rizzo, William B.

In: FEBS Letters, Vol. 429, No. 3, 16.06.1998, p. 225-228.

Research output: Contribution to journalArticle

Verhoeven, N. M. ; Jakobs, C. ; Carney, G. ; Somers, M. P. ; Wanders, R. J.A. ; Rizzo, William B. / Involvement of microsomal fatty aldehyde dehydrogenase in the α- oxidation of phytanic acid. In: FEBS Letters. 1998 ; Vol. 429, No. 3. pp. 225-228.
@article{bbcb2be231234e289329faf77ede2b1c,
title = "Involvement of microsomal fatty aldehyde dehydrogenase in the α- oxidation of phytanic acid",
abstract = "We investigated the role of microsomal fatty aldehyde dehydrogenase (FALDH) in the conversion of pristanal into pristanic acid. Cultured skin fibroblasts from controls and patients with Sjogren-Larsson syndrome (SLS) who are genetically deficient in FALDH activity were incubated with [2,3- 3H]phytanic acid. The release of aqueous-soluble radioactivity by the SLS cells was decreased to 25{\%} of normal, consistent with an intact formation of pristanal but a deficiency of further oxidation. SLS cells also accumulated four-fold more radioactivity in N-alkyl-phosphatidyl ethanolamine, which arises from incorporation of free aldehyde into phosphatidyl ethanolamine. Recombinant human FALDH expressed in Chinese hamster ovary cells readily oxidized pristanal and cultured fibroblasts from SLS patients showed a severe deficiency in FALDH activity (13{\%} of normal) when pristanal was used as substrate. Nevertheless, SLS patients did not accumulate phytanic acid in their plasma. We conclude that FALDH is involved in the oxidation of pristanal to pristanic acid and that this reaction is deficient in patients with SLS.",
keywords = "Aldehyde dehydrogenase, Peroxisomal disorder, Phytanic acid, Sjogren-Larsson syndrome",
author = "Verhoeven, {N. M.} and C. Jakobs and G. Carney and Somers, {M. P.} and Wanders, {R. J.A.} and Rizzo, {William B}",
year = "1998",
month = "6",
day = "16",
doi = "10.1016/S0014-5793(98)00574-2",
language = "English (US)",
volume = "429",
pages = "225--228",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Involvement of microsomal fatty aldehyde dehydrogenase in the α- oxidation of phytanic acid

AU - Verhoeven, N. M.

AU - Jakobs, C.

AU - Carney, G.

AU - Somers, M. P.

AU - Wanders, R. J.A.

AU - Rizzo, William B

PY - 1998/6/16

Y1 - 1998/6/16

N2 - We investigated the role of microsomal fatty aldehyde dehydrogenase (FALDH) in the conversion of pristanal into pristanic acid. Cultured skin fibroblasts from controls and patients with Sjogren-Larsson syndrome (SLS) who are genetically deficient in FALDH activity were incubated with [2,3- 3H]phytanic acid. The release of aqueous-soluble radioactivity by the SLS cells was decreased to 25% of normal, consistent with an intact formation of pristanal but a deficiency of further oxidation. SLS cells also accumulated four-fold more radioactivity in N-alkyl-phosphatidyl ethanolamine, which arises from incorporation of free aldehyde into phosphatidyl ethanolamine. Recombinant human FALDH expressed in Chinese hamster ovary cells readily oxidized pristanal and cultured fibroblasts from SLS patients showed a severe deficiency in FALDH activity (13% of normal) when pristanal was used as substrate. Nevertheless, SLS patients did not accumulate phytanic acid in their plasma. We conclude that FALDH is involved in the oxidation of pristanal to pristanic acid and that this reaction is deficient in patients with SLS.

AB - We investigated the role of microsomal fatty aldehyde dehydrogenase (FALDH) in the conversion of pristanal into pristanic acid. Cultured skin fibroblasts from controls and patients with Sjogren-Larsson syndrome (SLS) who are genetically deficient in FALDH activity were incubated with [2,3- 3H]phytanic acid. The release of aqueous-soluble radioactivity by the SLS cells was decreased to 25% of normal, consistent with an intact formation of pristanal but a deficiency of further oxidation. SLS cells also accumulated four-fold more radioactivity in N-alkyl-phosphatidyl ethanolamine, which arises from incorporation of free aldehyde into phosphatidyl ethanolamine. Recombinant human FALDH expressed in Chinese hamster ovary cells readily oxidized pristanal and cultured fibroblasts from SLS patients showed a severe deficiency in FALDH activity (13% of normal) when pristanal was used as substrate. Nevertheless, SLS patients did not accumulate phytanic acid in their plasma. We conclude that FALDH is involved in the oxidation of pristanal to pristanic acid and that this reaction is deficient in patients with SLS.

KW - Aldehyde dehydrogenase

KW - Peroxisomal disorder

KW - Phytanic acid

KW - Sjogren-Larsson syndrome

UR - http://www.scopus.com/inward/record.url?scp=0032537502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032537502&partnerID=8YFLogxK

U2 - 10.1016/S0014-5793(98)00574-2

DO - 10.1016/S0014-5793(98)00574-2

M3 - Article

VL - 429

SP - 225

EP - 228

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 3

ER -